<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-04-2912">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2004_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-23</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk</title>
        <partNumber>Part III</partNumber>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2004-02-11/html/04-2912.htm">
        <identifier type="FDsys Unique ID">D09002ee1c81686a6</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2004-02-11/pdf/04-2912.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c81687c3</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA, we, our) is issuing a final regulation declaring dietary supplements containing ephedrine alkaloids adulterated under the Federal Food, Drug, and Cosmetic Act (the act) because they present an unreasonable risk of illness or injury under the conditions of use recommended or suggested in labeling, or if no conditions of use are suggested or recommended in labeling, under ordinary conditions of use. We are taking this action based upon the well-known pharmacology of ephedrine alkaloids, the peer-reviewed scientific literature on the effects of ephedrine alkaloids, and the adverse events reported to have occurred in individuals following consumption of dietary supplements containing ephedrine alkaloids.</abstract>
    <identifier type="FR citation">69 FR 6788</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2004-02-11/04-2912</identifier>
    <identifier type="FR Doc No.">04-2912</identifier>
    <identifier type="former granule identifier">fr11fe04-40</identifier>
    <identifier type="Regulation ID Number">RIN 0910-AA59</identifier>
    <identifier type="billing code">4160-01-S</identifier>
    <identifier type="department code">Docket No. 1995N-0304</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2004-02-11/04-2912</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2004-02-11/html/04-2912.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2004-02-11/pdf/04-2912.pdf</url>
    </location>
    <physicalDescription>
        <extent>67 p.</extent>
    </physicalDescription>
    <part type="Part III">
        <extent unit="pages">
            <start>6788</start>
            <end>6854</end>
        </extent>
    </part>
    <identifier type="preferred citation">69 FR 6788</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 119</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  119</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 0910-AA59</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 0910-AA59</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Federal Register Vol. 69, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>04-2912</accessId>
        <partNumber>III</partNumber>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <effectiveDate>2004-04-12</effectiveDate>
        <departmentDoc>Docket No. 1995N-0304</departmentDoc>
        <rin number="0910-AA59"/>
        <billingCode>4160-01-S</billingCode>
        <frDocNumber>04-2912</frDocNumber>
        <action>Final rule.</action>
        <summary>The Food and Drug Administration (FDA, we, our) is issuing a final regulation declaring dietary supplements containing ephedrine alkaloids adulterated under the Federal Food, Drug, and Cosmetic Act (the act) because they present an unreasonable risk of illness or injury under the conditions of use recommended or suggested in labeling, or if no conditions of use are suggested or recommended in labeling, under ordinary conditions of use. We are taking this action based upon the well-known pharmacology of ephedrine alkaloids, the peer-reviewed scientific literature on the effects of ephedrine alkaloids, and the adverse events reported to have occurred in individuals following consumption of dietary supplements containing ephedrine alkaloids.</summary>
        <dates>This rule is effective on April 12, 2004.</dates>
        <contact>Wayne Amchin, Center for Food Safety and Applied Nutrition (HFS-007), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6733.</contact>
        <cfr title="21">
                                    
            <part number="119"/>
                                
        </cfr>
        <tocSubject1>Food for human consumption:</tocSubject1>
        <tocDoc>Dietary supplements containing ephedrine alkaloids, </tocDoc>
        <urlRef>DrugFacts.com</urlRef>
        <urlRef>http://nccam.nih.gov/health/alerts/ephedra/working-group.htm</urlRef>
        <urlRef>http://www.annals.org/cgi/content/full/138/12/1012</urlRef>
        <urlRef>http://www.annals.org/cgi/content/full/139/5_Part_1/385-b</urlRef>
        <urlRef>http://www.cdc.gov/nchs/fastats/lifexpec.htm</urlRef>
        <urlRef>http://www.cfsan.fda.gov/˜dms/ds-ltr3.html</urlRef>
        <urlRef>http://www.cfsan.fda.gov/˜dms/rafw-toc.html</urlRef>
        <urlRef>http://www.cfsan.fda.gov/˜dms/ssaguide.html</urlRef>
        <urlRef>http://www.crnusa.org/cantoxreportindex.html</urlRef>
        <urlRef>http://www.factsandcomparisons.com</urlRef>
        <urlRef>http://www.fda.gov/bbs/topics/NEWS/ephedra/letterslist.html</urlRef>
        <urlRef>http://www.fda.gov/bbs/topics/NEWS/ephedra/warning.html</urlRef>
        <urlRef>http://www.fda.gov/bbs/topics/NEWS/ephedra/whitepaper.html</urlRef>
        <urlRef>http://www.fda.gov/cder/guidance/1221dft.pdf</urlRef>
        <urlRef>http://www.fda.gov/cder/guidance/3602fnl.pdf</urlRef>
        <urlRef>http://www.fda.gov/cder/guidance/4461fnl.pdf</urlRef>
        <urlRef>http://www.fda.gov/OHRMS/DOCKETS/98fr/95n-0304-bkg0003-ref-07-01-index.htm</urlRef>
        <urlRef>http://www.foodriskclearinghouse.umd.edu/dspd.htm</urlRef>
        <urlRef>http://www.foodriskclearinghouse.umd.edu/smpds.htm</urlRef>
        <urlRef>http://www.hcup.ahrq.gov/HCUPnet.asp</urlRef>
        <urlRef>http://www.hhs.gov/infoquality/fda.html#i</urlRef>
        <urlRef>http://www.house.gov/reform/min/pdfs/</urlRef>
        <urlRef>http://www.laegemiddelstyrelsen.dk/en/news/letigen_6_en.asp</urlRef>
        <urlRef>http://www.nhlbi.nih.gov/guidelines/cholesterol</urlRef>
        <urlRef>http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm</urlRef>
        <urlRef>http://www.nnfa.org/facts</urlRef>
        <urlRef>http://www.rand.org/publications/randreview/issues/spring2003/evidence.html</urlRef>
        <urlRef>http://www.stedmans.com/</urlRef>
        <urlRef>http://www.washingtonpost.com/ac2/wp-dyn</urlRef>
        <urlRef>http://www.washingtonpost.com/wp-dyn/articles/A52270-2003Jan13.html</urlRef>
        <urlRef>http://www.whitehouse.gov/omb/circulars/a004/a-4.html</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1809733f7" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2004-02-11/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 69, no. 28</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2004-02-11</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>389 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2004-02-11">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2004-02-11</identifier>
        <identifier type="local">P0b002ee1809733f7</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr11fe04</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2004-02-11</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2004-02-11/pdf/FR-2004-02-11.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2004-02-11/xml/FR-2004-02-11.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>6525</start>
                <end>6903</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-23</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-07</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2004-02-11</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2004-02-11</accessId>
            <volume>69</volume>
            <issue>28</issue>
        </extension>
    </relatedItem>
</mods>
